Company / AR per Share
GYRE THERAPEUTICS, INC. AR per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.36
FY2025
5-year range
$0.08 / $0.36
FY2021-FY2025
Trend
+40.8%
vs FY2024
Sector context
#73 of 115
Health Care
What the data says
At $0.36, GYRE THERAPEUTICS, INC.'s ar per share ranks #73 of 115 in the Health Care sector. Improved from $0.08 to $0.36 over the past 4 years.
Based on SEC 10-K filings.
0.36 in FY2025 with a 5-year CAGR of +5.5%.
Improved from $0.08 to $0.36 over the past 4 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Sector benchmark
#73 of 115 in Health CareTop 63% of 115This company $0.36 Sector average $27.05
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 40.8% year-over-year.
- Ranks #73 out of 115 companies in the Health Care sector.
- Peak ar per share was recorded in FY2019.
- Lowest ar per share in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.36 | +40.8% |
| FY2024 | $0.26 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.08 | -70.1% |
| FY2020 | $0.28 | -78.1% |
| FY2019 | $1.25 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026